Drug Development and Industrial Pharmacy · 2017 · 110 citations · 17 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryPharmaceutical FormulationDrug EncapsulationNanocarriers For TherapeuticsNanomedicineNanoparticle CharacterizationNanoparticle DesignNanoparticle FormulationsEmulsificationEx Vivo DeliveryLipid Nanoparticle CharacterizationLipid NanoparticlesLipid-based Nanoparticle FormulationNanoparticle Drug DistributionPharmacodynamic OptimizationSolid Lipid Nanoparticle Encapsulation
The purpose of this work was to formulate piperine solid lipid nanoparticle (SLN) dispersion to exploit its efficacy orally and topically. Piperine SLN were prepared by melt emulsification method and formula was optimized by the application of 32 factorial design. The nanoparticulate dispersion was evaluated for particle size, entrapment efficiency and zeta potential (ZP). Optimized batch (128.80 nm average size, 78.71% entrapment efficiency and −23.34 mV zeta potential) was characterized for differential scanning calorimetry (DSC), X-ray diffraction which revealed amorphous nature of piperine in SLN. The prepared SLN were administered orally and topically to CFA-induced arthritic rats. Ex vivo study using Franz diffusion cell indicate that piperine from SLN gel formulation accumulates in the skin. Pharmacodynamic study result indicates both the topical and oral piperine evoked a significant response compared to orally administered chloroquine suspension. The results of ELISA show significant reduction in TNFα in treated rat which might be the reason behind the DMARD action of piperine SLN.
17
W. Mehnert, Karsten Mäder · Advanced Drug Delivery Reviews · 2012 · 933 citations
Jun Soo Bang, Da Hee Oh, Hyun Mi Choi et al. · Arthritis Research & Therapy · 2009 · 391 citations · Full text